Christoph U. Correll, MD

Department of Psychiatry, Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York, Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, German Center for Mental Health (DZPG), partner site Berlin, Germany

Article

Frequency and Correlates of DSM-5 Attenuated Psychosis Syndrome in a Sample of Adolescent Inpatients With Nonpsychotic Psychiatric Disorders

November 25, 2015

Miriam Gerstenberg , Marta Hauser , Aseel Al-Jadiri , et al

Original Research

Sudden Cardiac Death in Young Adults With Previous Hospital-Based Psychiatric Inpatient and Outpatient Treatment: A Nationwide Cohort Study From Denmark

September 23, 2015

Bjarke Risgaard , Kristine Waagstein , Bo Gregers Winkel , et al

Educational Activity

Making the Link Between Science and Symptoms in Schizophrenia

June 24, 2015

John M. Kane , Christoph U. Correll

Original Research

The RAISE: First-Episode Psychosis

March 25, 2015

Read an article describing The RAISE Early Treatment Program for First-Episode Psychosis, the background and study design of the program.

John M. Kane , Nina R. Schooler , Patricia Marcy , et al

Educational Activity

Recognition of Patients Who Would Benefit From LAI Antipsychotic Treatment: How to Assess Adherence

November 24, 2014

Christoph U. Correll

Educational Activity

Mechanism of Action of Antipsychotic Medications

September 25, 2014

Christoph U. Correll

Educational Activity

The Role of the Extended Health Care Team in Successful LAI Therapy: Education to Overcome Barriers

September 25, 2014

Christoph U. Correll

InfoPack

Clinical and Cost Implications of Treating Schizophrenia: Safety, Efficacy, Relapse Prevention, and Patient Outcomes

August 26, 2014

John M. Kane , Christoph U. Correll , Philip D. Harvey , et al

Original Research

Body Mass Index Identified as an Independent Predictor of Psychiatric Readmission

June 27, 2014

Peter Manu , Sameer Khan , Rajiv Radhakrishnan , et al

Original Research

National Trends in Second-Generation Antipsychotic Augmentation for Nonpsychotic Depression

May 15, 2014

Tobias Gerhard , Ayse Akincigil , Christoph U. Correll , et al

ASCP Corner

The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches

March 15, 2014

Swapnil Gupta , John D. Cahill , Mohini Ranganathan , et al

Commentary

Schizophrenia: Mechanism of Action of Current and Novel Treatments

March 7, 2014

Christoph U. Correll , John M. Kane

« 1 … 4 5 6 7 8 … 10 »

Christoph U. Correll, MD

Frequency and Correlates of DSM-5 Attenuated Psychosis Syndrome in a Sample of Adolescent Inpatients With Nonpsychotic Psychiatric Disorders

Sudden Cardiac Death in Young Adults With Previous Hospital-Based Psychiatric Inpatient and Outpatient Treatment: A Nationwide Cohort Study From Denmark

Making the Link Between Science and Symptoms in Schizophrenia

The RAISE: First-Episode Psychosis

Recognition of Patients Who Would Benefit From LAI Antipsychotic Treatment: How to Assess Adherence

Mechanism of Action of Antipsychotic Medications

The Role of the Extended Health Care Team in Successful LAI Therapy: Education to Overcome Barriers

Clinical and Cost Implications of Treating Schizophrenia: Safety, Efficacy, Relapse Prevention, and Patient Outcomes

Body Mass Index Identified as an Independent Predictor of Psychiatric Readmission

National Trends in Second-Generation Antipsychotic Augmentation for Nonpsychotic Depression

The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches

Schizophrenia: Mechanism of Action of Current and Novel Treatments

ELSEWHERE:

FOLLOW US:

Christoph U. Correll, MD

Frequency and Correlates of DSM-5 Attenuated Psychosis Syndrome in a Sample of Adolescent Inpatients With Nonpsychotic Psychiatric Disorders

Sudden Cardiac Death in Young Adults With Previous Hospital-Based Psychiatric Inpatient and Outpatient Treatment: A Nationwide Cohort Study From Denmark

Making the Link Between Science and Symptoms in Schizophrenia

The RAISE: First-Episode Psychosis

Recognition of Patients Who Would Benefit From LAI Antipsychotic Treatment: How to Assess Adherence

Mechanism of Action of Antipsychotic Medications

The Role of the Extended Health Care Team in Successful LAI Therapy: Education to Overcome Barriers

Clinical and Cost Implications of Treating Schizophrenia: Safety, Efficacy, Relapse Prevention, and Patient Outcomes

Body Mass Index Identified as an Independent Predictor of Psychiatric Readmission

National Trends in Second-Generation Antipsychotic Augmentation for Nonpsychotic Depression

The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches

Schizophrenia: Mechanism of Action of Current and Novel Treatments

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles